Can local ablative techniques replace surgery for locally advanced pancreatic cancer?

Area of Science:

• Oncology
• Surgical Oncology
• Gastroenterology

Background:

• Pancreatic ductal adenocarcinoma (PDAC) treatment relies on surgical resection for cure.
• Locally advanced pancreatic cancer (LAPC) is often unresectable at diagnosis due to vascular invasion.
• Induction therapies like FOLFIRINOX improve resectability rates, but many LAPC cases remain unresectable.

Purpose of the Study:

• To review the applicability of locally ablative techniques for unresectable LAPC.
• To propose a new patient subgroup: "Inconvertible LAPC."
• To highlight the need for evidence-based guidelines for ablative therapies in this group.

Main Methods:

• Literature review of ablative techniques for PDAC.
• Analysis of current treatment guidelines for LAPC.
• Definition of criteria for "Inconvertible LAPC."

Main Results:

• High-level evidence for ablative techniques in PDAC is limited.
• Current LAPC guidelines are not consistently applied in studies of ablative techniques.
• Persistent unresectability after induction therapy defines the "Inconvertible LAPC" group.

Conclusions:

• "Inconvertible LAPC" may benefit from locally ablative techniques as an alternative to surgery.
• Further research and trials are needed to establish evidence for ablative therapies in this subgroup.
• Defining "Inconvertible LAPC" can guide future research and optimize treatment strategies.